Search

Kevin M. Johnson

Examiner (ID: 17187)

Most Active Art Unit
1793
Art Unit(s)
1793, 1732
Total Applications
255
Issued Applications
85
Pending Applications
85
Abandoned Applications
85

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18443527 [patent_doc_number] => 11679078 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-06-20 [patent_title] => Ophthalmic formulations and related methods [patent_app_type] => utility [patent_app_number] => 17/689212 [patent_app_country] => US [patent_app_date] => 2022-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18967 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17689212 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/689212
Ophthalmic formulations and related methods Mar 7, 2022 Issued
Array ( [id] => 17850632 [patent_doc_number] => 20220280673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => BIODEGRADABLE NON-WOVEN FABRIC SHEET [patent_app_type] => utility [patent_app_number] => 17/653172 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653172 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653172
BIODEGRADABLE NON-WOVEN FABRIC SHEET Mar 1, 2022 Abandoned
Array ( [id] => 17836278 [patent_doc_number] => 20220273583 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => METHOD FOR DELIVERING AN AGENT TO POSTERIOR SEGMENT OF AN EYE AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/681121 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12033 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681121 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681121
Method for delivering an agent to posterior segment of an eye and uses thereof Feb 24, 2022 Issued
Array ( [id] => 17702700 [patent_doc_number] => 20220202706 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => SUSTAINED RELEASE BIODEGRADABLE INTRACANALICULAR INSERTS COMPRISING A HYDROGEL AND CYCLOSPORINE [patent_app_type] => utility [patent_app_number] => 17/681238 [patent_app_country] => US [patent_app_date] => 2022-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37915 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/681238
Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine Feb 24, 2022 Issued
Array ( [id] => 19195340 [patent_doc_number] => 11992559 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-05-28 [patent_title] => Microsphere formulations comprising lurasidone and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 17/679385 [patent_app_country] => US [patent_app_date] => 2022-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 5349 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679385 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/679385
Microsphere formulations comprising lurasidone and methods for making and using the same Feb 23, 2022 Issued
Array ( [id] => 17640478 [patent_doc_number] => 20220168216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/675654 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27717 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17675654 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/675654
TOPICAL COMPOSITIONS AND METHODS OF USING THE SAME Feb 17, 2022 Pending
Array ( [id] => 18550003 [patent_doc_number] => 20230248001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-10 [patent_title] => STORAGE STABLE SOLUTION COMPRISING HYPOCHLOROUS ACID AND/OR HYPOCHLORITE [patent_app_type] => utility [patent_app_number] => 17/668356 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17668356 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/668356
STORAGE STABLE SOLUTION COMPRISING HYPOCHLOROUS ACID AND/OR HYPOCHLORITE Feb 8, 2022 Abandoned
Array ( [id] => 17576870 [patent_doc_number] => 20220133725 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => PULSE DOSING REGIMEN AND METHODS OF TREATMENT [patent_app_type] => utility [patent_app_number] => 17/572491 [patent_app_country] => US [patent_app_date] => 2022-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12651 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572491 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/572491
Pulse dosing regimen and methods of treatment Jan 9, 2022 Issued
Array ( [id] => 17561581 [patent_doc_number] => 20220125730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-28 [patent_title] => METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET [patent_app_type] => utility [patent_app_number] => 17/570548 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12208 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17570548 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/570548
METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET Jan 6, 2022 Abandoned
Array ( [id] => 17532505 [patent_doc_number] => 20220111114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => EMBOLIC MICROSPHERES [patent_app_type] => utility [patent_app_number] => 17/557175 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5694 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17557175 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/557175
EMBOLIC MICROSPHERES Dec 20, 2021 Pending
Array ( [id] => 19554710 [patent_doc_number] => 20240366502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => ORODISPERSIBLE POWDER COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/255675 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9134 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18255675 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/255675
Orodispersible powder composition Dec 20, 2021 Issued
Array ( [id] => 17685804 [patent_doc_number] => 20220193096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY [patent_app_type] => utility [patent_app_number] => 17/645239 [patent_app_country] => US [patent_app_date] => 2021-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57429 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17645239 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/645239
INHIBITORS OF NCCA-ATP CHANNELS FOR THERAPY Dec 19, 2021 Abandoned
Array ( [id] => 18970430 [patent_doc_number] => 20240050522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES [patent_app_type] => utility [patent_app_number] => 18/266542 [patent_app_country] => US [patent_app_date] => 2021-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29315 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -81 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266542 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/266542
COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES Dec 9, 2021 Pending
Array ( [id] => 18901260 [patent_doc_number] => 20240016745 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => TIMED-ELUTION MASKING PARTICLES AND ORAL PHARMACEUTICAL COMPOSITION CONTAINING THE SAME [patent_app_type] => utility [patent_app_number] => 18/265042 [patent_app_country] => US [patent_app_date] => 2021-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15435 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265042 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/265042
TIMED-ELUTION MASKING PARTICLES AND ORAL PHARMACEUTICAL COMPOSITION CONTAINING THE SAME Dec 3, 2021 Pending
Array ( [id] => 18815852 [patent_doc_number] => 20230390191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-07 [patent_title] => SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES [patent_app_type] => utility [patent_app_number] => 18/254756 [patent_app_country] => US [patent_app_date] => 2021-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21987 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254756 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/254756
SELF-REGULATING BIOADHESIVES FOR WET SUBSTRATES Nov 29, 2021 Pending
Array ( [id] => 17748077 [patent_doc_number] => 20220226280 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => COMPOSITIONS AND METHODS FOR INCREASED GLUCOSE UPTAKE AND FAT METABOLISM [patent_app_type] => utility [patent_app_number] => 17/533715 [patent_app_country] => US [patent_app_date] => 2021-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6944 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/533715
COMPOSITIONS AND METHODS FOR INCREASED GLUCOSE UPTAKE AND FAT METABOLISM Nov 22, 2021 Abandoned
Array ( [id] => 19065616 [patent_doc_number] => 20240100042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/253878 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5920 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253878 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/253878
BRUCINE GEL PLASTER AND PREPARATION METHOD AND USE THEREOF Nov 18, 2021 Pending
Array ( [id] => 18860061 [patent_doc_number] => 20230414495 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF [patent_app_type] => utility [patent_app_number] => 18/035816 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035816 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035816
PUNCTAL PLUGS CONTAINING MICELLE-ENCAPSULATED OPHTHALMIC PHARMACEUTICALS AND METHODS FOR MAKING THEREOF Nov 7, 2021 Abandoned
Array ( [id] => 17412681 [patent_doc_number] => 20220047585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => PREVENTING OR TREATING AGENT FOR GLAUCOMA [patent_app_type] => utility [patent_app_number] => 17/516145 [patent_app_country] => US [patent_app_date] => 2021-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17516145 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/516145
PREVENTING OR TREATING AGENT FOR GLAUCOMA Oct 31, 2021 Abandoned
Array ( [id] => 17953502 [patent_doc_number] => 11479593 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-25 [patent_title] => Compositions, formulations and interleukin production and purification [patent_app_type] => utility [patent_app_number] => 17/512315 [patent_app_country] => US [patent_app_date] => 2021-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 182 [patent_figures_cnt] => 293 [patent_no_of_words] => 82778 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 188 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17512315 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/512315
Compositions, formulations and interleukin production and purification Oct 26, 2021 Issued
Menu